Factor XIII
Indication :
Dosing :
IV
40 IU/kg at a rate not to exceed 4 mL/min. Maintain 5% to 20% trough level of FXIII activity. For routine prophylaxis, administer every 28 days.
Adverse Effect :
Joint inflammation, hypersensitivity, rash, pruritus, erythema, hematoma, arthralgia, headache, elevated thrombin-antithrombin levels, increased blood lactate dehydrogenase, factor XIII antibodies.
Hepatic Dose :
No dosage adjustments are recommended.